Literature DB >> 23420844

Glutamate acts as a partial inverse agonist to metabotropic glutamate receptor with a single amino acid mutation in the transmembrane domain.

Masataka Yanagawa1, Takahiro Yamashita, Yoshinori Shichida.   

Abstract

Metabotropic glutamate receptor (mGluR), a prototypical family 3 G protein-coupled receptor (GPCR), has served as a model for studying GPCR dimerization, and growing evidence has revealed that a glutamate-induced dimeric rearrangement promotes activation of the receptor. However, structural information of the seven-transmembrane domain is severely limited, in contrast to the well studied family 1 GPCRs including rhodopsins and adrenergic receptors. Homology modeling of mGluR8 transmembrane domain with rhodopsin as a template suggested the presence of a conserved water-mediated hydrogen-bonding network between helices VI and VII, which presumably constrains the receptor in an inactive conformation. We therefore conducted a mutational analysis to assess structural similarities between mGluR and family 1 GPCRs. Mutational experiments confirmed that the disruption of the hydrogen-bonding network by T789Y(6.43) mutation induced high constitutive activity. Unexpectedly, this high constitutive activity was suppressed by glutamate, the natural agonist ligand, indicating that glutamate acts as a partial inverse agonist to this mutant. Fluorescence energy transfer analysis of T789Y(6.43) suggested that the glutamate-induced reduction of the activity originated not from the dimeric rearrangement but from conformational changes within each protomer. Double mutational analysis showed that the specific interaction between Tyr-789(6.43) and Gly-831(7.45) in T789Y(6.43) mutant was important for this phenotype. Therefore, the present study is consistent with the notion that the metabotropic glutamate receptor shares a common activation mechanism with family 1 GPCRs, where rearrangement between helices VI and VII causes the active state formation.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23420844      PMCID: PMC3617263          DOI: 10.1074/jbc.M112.437780

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  34 in total

1.  The retinal conformation and its environment in rhodopsin in light of a new 2.2 A crystal structure.

Authors:  Tetsuji Okada; Minoru Sugihara; Ana-Nicoleta Bondar; Marcus Elstner; Peter Entel; Volker Buss
Journal:  J Mol Biol       Date:  2004-09-10       Impact factor: 5.469

2.  GPCR-OKB: the G Protein Coupled Receptor Oligomer Knowledge Base.

Authors:  George Khelashvili; Kevin Dorff; Jufang Shan; Marta Camacho-Artacho; Lucy Skrabanek; Bas Vroling; Michel Bouvier; Lakshmi A Devi; Susan R George; Jonathan A Javitch; Martin J Lohse; Graeme Milligan; Richard R Neubig; Krzysztof Palczewski; Marc Parmentier; Jean-Philippe Pin; Gerrit Vriend; Fabien Campagne; Marta Filizola
Journal:  Bioinformatics       Date:  2010-05-25       Impact factor: 6.937

Review 3.  Pharmacogenomic and structural analysis of constitutive g protein-coupled receptor activity.

Authors:  Martine J Smit; Henry F Vischer; Remko A Bakker; Aldo Jongejan; Henk Timmerman; Leonardo Pardo; Rob Leurs
Journal:  Annu Rev Pharmacol Toxicol       Date:  2007       Impact factor: 13.820

4.  Common structural requirements for heptahelical domain function in class A and class C G protein-coupled receptors.

Authors:  Virginie Binet; Béatrice Duthey; Jennifer Lecaillon; Claire Vol; Julie Quoyer; Gilles Labesse; Jean-Philippe Pin; Laurent Prézeau
Journal:  J Biol Chem       Date:  2007-02-19       Impact factor: 5.157

5.  Crystal structure of metarhodopsin II.

Authors:  Hui-Woog Choe; Yong Ju Kim; Jung Hee Park; Takefumi Morizumi; Emil F Pai; Norbert Krauss; Klaus Peter Hofmann; Patrick Scheerer; Oliver P Ernst
Journal:  Nature       Date:  2011-03-09       Impact factor: 49.962

6.  Efficient selection for high-expression transfectants with a novel eukaryotic vector.

Authors:  H Niwa; K Yamamura; J Miyazaki
Journal:  Gene       Date:  1991-12-15       Impact factor: 3.688

7.  Modeling and mutagenesis of the binding site of Calhex 231, a novel negative allosteric modulator of the extracellular Ca(2+)-sensing receptor.

Authors:  Christophe Petrel; Albane Kessler; Fouzia Maslah; Philippe Dauban; Robert H Dodd; Didier Rognan; Martial Ruat
Journal:  J Biol Chem       Date:  2003-09-23       Impact factor: 5.157

8.  Mutational analysis and molecular modeling of the binding pocket of the metabotropic glutamate 5 receptor negative modulator 2-methyl-6-(phenylethynyl)-pyridine.

Authors:  Pari Malherbe; Nicole Kratochwil; Marie-Thérèse Zenner; Jenny Piussi; Catherine Diener; Claudia Kratzeisen; Christophe Fischer; Richard H P Porter
Journal:  Mol Pharmacol       Date:  2003-10       Impact factor: 4.436

9.  Activation switch in the transmembrane domain of metabotropic glutamate receptor.

Authors:  Masataka Yanagawa; Takahiro Yamashita; Yoshinori Shichida
Journal:  Mol Pharmacol       Date:  2009-04-27       Impact factor: 4.436

10.  Mutational analysis and molecular modeling of the allosteric binding site of a novel, selective, noncompetitive antagonist of the metabotropic glutamate 1 receptor.

Authors:  Pari Malherbe; Nicole Kratochwil; Frédéric Knoflach; Marie-Thérèse Zenner; James N C Kew; Claudia Kratzeisen; Hans P Maerki; Geo Adam; Vincent Mutel
Journal:  J Biol Chem       Date:  2002-12-30       Impact factor: 5.157

View more
  4 in total

Review 1.  GPCR activation: protonation and membrane potential.

Authors:  Xuejun C Zhang; Kening Sun; Laixing Zhang; Xuemei Li; Can Cao
Journal:  Protein Cell       Date:  2013-09-20       Impact factor: 14.870

2.  mGluR5: exploration of orthosteric and allosteric ligand binding pockets and their applications to drug discovery.

Authors:  Christina Mølck; Kasper Harpsøe; David E Gloriam; Jesper M Mathiesen; Søren M Nielsen; Hans Bräuner-Osborne
Journal:  Neurochem Res       Date:  2014-02-04       Impact factor: 3.996

Review 3.  Progress toward advanced understanding of metabotropic glutamate receptors: structure, signaling and therapeutic indications.

Authors:  Shen Yin; Colleen M Niswender
Journal:  Cell Signal       Date:  2014-05-02       Impact factor: 4.315

4.  Origin of the low thermal isomerization rate of rhodopsin chromophore.

Authors:  Masataka Yanagawa; Keiichi Kojima; Takahiro Yamashita; Yasushi Imamoto; Take Matsuyama; Koji Nakanishi; Yumiko Yamano; Akimori Wada; Yasushi Sako; Yoshinori Shichida
Journal:  Sci Rep       Date:  2015-06-10       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.